EUVIMEDEUVIMED entdecken
Crossref

Crystal Engineering of Daidzein: Development, Characterization, and In Vitro Cytotoxicity Against Human Breast Cancer Cells (MCF-7)

Preet Kaur, Manju Pandey, Brijesh singh

International Journal of Drug Delivery Technology · 30.07.2026 · 16 (71s)

DOI: 10.25258/ijddt.16.71s.200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.07.2026. Verfasst von Preet Kaur und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Kaur, P., Pandey, M., & singh, B. (2026). Crystal Engineering of Daidzein: Development, Characterization, and In Vitro Cytotoxicity Against Human Breast Cancer Cells (MCF-7). International Journal of Drug Delivery Technology, 16(71s). https://doi.org/10.25258/ijddt.16.71s.200

Vancouver

Kaur P, Pandey M, singh B. Crystal Engineering of Daidzein: Development, Characterization, and In Vitro Cytotoxicity Against Human Breast Cancer Cells (MCF-7). International Journal of Drug Delivery Technology. 2026;16(71s). doi:10.25258/ijddt.16.71s.200

BibTeX
@article{Kaur2026,
  author = {Kaur, Preet and Pandey, Manju and singh, Brijesh},
  title = {Crystal Engineering of Daidzein: Development, Characterization, and In Vitro Cytotoxicity Against Human Breast Cancer Cells (MCF-7)},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {71s},
  doi = {10.25258/ijddt.16.71s.200}
}
Kostenlos starten →